Regulation and targets of receptor tyrosine kinases

被引:206
作者
Pawson, T [1 ]
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
关键词
phosphotyrosine; SH2; domains; protein interactions;
D O I
10.1016/S0959-8049(02)80597-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ligand-mediated activation of receptor tyrosine kinases (RTKs) results in autophosphorylation of both the receptor catalytic domain and noncatalytic regions of the cytoplasmic domain. Catalytic domain phosphorylation leads to activation and potentiation of receptor kinase activity. Noncatalytic domain phosphorylation creates docking sites for downstream cytoplasmic targets, which bind to specific receptor phosphotyrosine residues. Downstream signaling pathways are constructed in a modular fashion. In addition to SH2 and PTB (phosphotyrosine binding) domains, downstream signal proteins also contain domains that recognize other protein and phospholipid motifs. The arrangement and re-arrangement of various combinations of modular domains in different signaling proteins (combinatorial use) has allowed for the creation of complex signaling networks and pathways. In addition to performing catalytic functions, signaling proteins serve as scaffolds for the assembly of multiprotein signaling complexes, as adaptors, as transcription factors and as signal pathway regulators. Recent results show that the juxtamembrane region of Eph receptors is important in receptor autoregulation. Mutations in the juxtamembrane region of several RTKs have been shown to play a role in oncogenesis. It is likely that dysregulation of other modular components of signaling pathways also plays a role in oncogenic transformation. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:S3 / S10
页数:8
相关论文
共 29 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]   Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events [J].
Baxter, RM ;
Secrist, JP ;
Vaillancourt, RR ;
Kazlauskas, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :17050-17055
[3]   Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of eph receptors [J].
Binns, KL ;
Taylor, PP ;
Sicheri, F ;
Pawson, T ;
Holland, SJ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (13) :4791-4805
[4]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[5]  
Deininger MWN, 2001, BLOOD, V98, p344B
[6]   Eph receptors and ephrin ligands: embryogenesis to tumorigenesis [J].
Dodelet, VC ;
Pasquale, EB .
ONCOGENE, 2000, 19 (49) :5614-5619
[7]   Protein tyrosine kinase structure and function [J].
Hubbard, SR ;
Till, JH .
ANNUAL REVIEW OF BIOCHEMISTRY, 2000, 69 :373-398
[8]   Signaling - 2000 and beyond [J].
Hunter, T .
CELL, 2000, 100 (01) :113-127
[9]  
Krystal GW, 1996, CANCER RES, V56, P370
[10]  
Lai KMV, 2000, GENE DEV, V14, P1132